The unit that ran the gene therapy trial during which 18-year-old Jesse
Gelsinger died last year will no longer carry out clinical studies. The
University of Pennsylvania in Philadelphia announced last week that its
Institute for Human Gene Therapy, directed by James Wilson, will now concentrate
on basic research. The decision comes as a serious blow to an institute that
once led the world in moving gene therapy from the lab to the clinic. Wilson
said in a statement that the institute would develop “a foundation of science
necessary to assure the ultimate success of this field.”
To continue reading, today with our introductory offers
Advertisement
More from 91av
Explore the latest news, articles and features
Popular articles
Trending 91av articles
1
PCOS postpones perimenopause and allows pregnancies at older ages
2
Red-light therapy does have health benefits but not the ones you think
3
Man destined for Alzheimer's may have been saved by accidental therapy
4
Woman in cancer remission without treatment in highly unusual case
5
A lost ancient script reveals how writing as we know it really began
6
Coffee's mood-boosting effects aren't just down to caffeine
7
Where has the deadly hantavirus come from and how does it spread?
8
300-year-old experiment could become world's best dark matter detector
9
Hantavirus outbreak will not cause a covid-style pandemic, says WHO
10
Extinct relative of koalas discovered in Western Australia
